G1 THERAPEUTICS, INC. Selling, General and Administrative Expense
G1 THERAPEUTICS, INC. reported Selling, General and Administrative Expense of $13.61 million for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2024-08-08
- G1 THERAPEUTICS, INC. selling, general and administrative expense for the quarter ending 2024-06-30 was $13.61M, a 21.93% decline year-over-year.
- G1 THERAPEUTICS, INC. selling, general and administrative expense for the quarter ending 2024-03-31 was $15.13M, a 30.46% decline year-over-year.
- G1 THERAPEUTICS, INC. selling, general and administrative expense for the quarter ending 2023-12-31 was $15.17M, a 35.62% decline year-over-year.
- G1 THERAPEUTICS, INC. selling, general and administrative expense for the quarter ending 2023-09-30 was $16.78M, a 31.32% decline year-over-year.
- G1 THERAPEUTICS, INC. selling, general and administrative expense for fiscal 2023 was $71.13M, a 29.16% decline from fiscal 2022.
- G1 THERAPEUTICS, INC. selling, general and administrative expense for fiscal 2022 was $100.42M, a 4.94% increase from fiscal 2021.
- G1 THERAPEUTICS, INC. selling, general and administrative expense for fiscal 2021 was $95.69M, a 39.72% increase from fiscal 2020.
- G1 THERAPEUTICS, INC. selling, general and administrative expense for fiscal 2020 was $68.49M, a 71.06% increase from fiscal 2019.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2024-06-30 | $13.61M 10-Q · filed 2024-08-08 | $28.74M 10-Q · filed 2024-08-08 | $43.90M derived: sum of 3 quarters · filed 2024-08-08 | $60.68M derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | $15.13M 10-Q · filed 2024-05-01 | $30.29M derived: sum of 2 quarters · filed 2024-05-01 | $47.07M derived: sum of 3 quarters · filed 2024-05-01 | $64.51M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-12-31 | $15.17M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $31.95M derived: sum of 2 quarters · filed 2024-02-28 | $49.38M derived: sum of 3 quarters · filed 2024-08-08 | $71.13M 10-K · filed 2024-02-28 |
| 2023-09-30 | $16.78M 10-Q · filed 2023-11-01 | $34.21M derived: sum of 2 quarters · filed 2024-08-08 | $55.97M 10-Q · filed 2023-11-01 | $79.52M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-06-30 | $17.43M 10-Q · filed 2024-08-08 | $39.19M 10-Q · filed 2024-08-08 | $62.74M derived: sum of 3 quarters · filed 2024-08-08 | $87.17M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $21.75M 10-Q · filed 2024-05-01 | $45.31M derived: sum of 2 quarters · filed 2024-05-01 | $69.74M derived: sum of 3 quarters · filed 2024-05-01 | $95.46M derived: sum of 4 quarters · filed 2024-05-01 |
| 2022-12-31 | $23.56M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $47.99M derived: sum of 2 quarters · filed 2024-02-28 | $73.71M derived: sum of 3 quarters · filed 2024-02-28 | $100.42M 10-K · filed 2024-02-28 |
| 2022-09-30 | $24.43M 10-Q · filed 2023-11-01 | $50.15M derived: sum of 2 quarters · filed 2023-11-01 | $76.86M 10-Q · filed 2023-11-01 | $100.08M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $25.72M 10-Q · filed 2023-08-02 | $52.42M 10-Q · filed 2023-08-02 | $75.64M derived: sum of 3 quarters · filed 2024-02-28 | $99.91M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $26.71M 10-Q · filed 2023-05-03 | $49.93M derived: sum of 2 quarters · filed 2024-02-28 | $74.19M derived: sum of 3 quarters · filed 2024-02-28 | $99.43M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $23.22M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $47.49M derived: sum of 2 quarters · filed 2024-02-28 | $72.72M derived: sum of 3 quarters · filed 2024-02-28 | $95.69M 10-K · filed 2024-02-28 |
| 2021-09-30 | $24.27M 10-Q · filed 2022-11-02 | $49.50M derived: sum of 2 quarters · filed 2022-11-02 | $72.47M 10-Q · filed 2022-11-02 | $96.73M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $25.24M 10-Q · filed 2022-08-03 | $48.21M 10-Q · filed 2022-08-03 | $72.47M derived: sum of 3 quarters · filed 2023-03-01 | $90.88M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $22.97M 10-Q · filed 2022-05-04 | $47.23M derived: sum of 2 quarters · filed 2023-03-01 | $65.64M derived: sum of 3 quarters · filed 2023-03-01 | $80.07M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $24.26M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $42.67M derived: sum of 2 quarters · filed 2023-03-01 | $57.10M derived: sum of 3 quarters · filed 2023-03-01 | $68.49M 10-K · filed 2023-03-01 |
| 2020-09-30 | $18.41M 10-Q · filed 2021-11-03 | $32.84M derived: sum of 2 quarters · filed 2021-11-03 | $44.23M 10-Q · filed 2021-11-03 | |
| 2020-06-30 | $14.43M 10-Q · filed 2021-08-04 | $25.82M 10-Q · filed 2021-08-04 | ||
| 2020-03-31 | $11.39M 10-Q · filed 2021-05-05 | |||
| 2019-12-31 | $40.04M 10-K · filed 2022-02-23 |